on 26 Nov 2019
Last Applicant/ Owned by
FRIEDRICH-MIESCHER-STR. 15
T�BINGEN
DE
72076
Serial Number
88149613 filed on 10th Oct 2018
Registration Number
5918021 registered on 26th Nov 2019
Correspondent Address
Jennifer Fraser
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and aller Read More
Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
N/A
N/A
Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
N/A
N/A
Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements namely, dietary food supplements
N/A
N/A
Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
N/A
N/A
No 88149613
No Service Mark
No 067249-0029
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
04th Dec 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
26th Nov 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
25th May 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
26th Nov 2019 | REGISTERED-PRINCIPAL REGISTER |
10th Sep 2019 | PUBLISHED FOR OPPOSITION |
10th Sep 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
21st Aug 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
07th Aug 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
07th Aug 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
07th Aug 2019 | EXAMINERS AMENDMENT E-MAILED |